Literature DB >> 16132180

Characterization of the humoral immune response of experimentally infected and vaccinated pigs to swine influenza viral proteins.

W-I Kim1, W-H Wu, B Janke, K-J Yoon.   

Abstract

The value of serologic tests for diagnosis of swine influenza virus (SIV) infection has been diminished by the emergence of new subtypes and by antigenic drift within subtype. The intensive use of vaccination also has complicated interpretation of serology results. Serologic assays are needed that can detect infection regardless of subtype or antigenic variation and that can differentiate antibody induced by infection from that induced by vaccination. In this study, the antibody responses to specific viral proteins in pigs infected by or vaccinated for SIV were characterized by Western immunoblot. Both IgM and IgG against hemagglutinin, nucleoprotein, NS1 and NS2 were detected in experimentally infected pigs by 7 days post inoculation (DPI). IgG against these proteins was still detectable at the end of the study (28 DPI). In contrast, IgG against neuraminidase and M1 was not detected until 14 DPI and no IgM against these proteins was detected. In vaccinated pigs, no antibody against NS1 was detected while antibody responses to other proteins were identical to those in exposed pigs. In conclusion, nucleoprotein may be a suitable antigen for use in a subtype-unrestricted serologic assay. NS1 protein may be suitable for a serologic assay that differentiates between infected and vaccinated pigs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132180     DOI: 10.1007/s00705-005-0615-9

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  6 in total

1.  Genetic and pathobiologic characterization of pandemic H1N1 2009 influenza viruses from a naturally infected swine herd.

Authors:  Hana M Weingartl; Yohannes Berhane; Tamiko Hisanaga; James Neufeld; Helen Kehler; Carissa Emburry-Hyatt; Kathleen Hooper-McGreevy; Samantha Kasloff; Brett Dalman; Jan Bystrom; Soren Alexandersen; Yan Li; John Pasick
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

2.  Antibodies to PB1-F2 protein are induced in response to influenza A virus infection.

Authors:  Ingrid Krejnusová; Hana Gocníková; Magdaléna Bystrická; Hana Blaskovicová; Katarína Poláková; Jonathan Yewdell; Jack Bennink; Gustáv Russ
Journal:  Arch Virol       Date:  2009-08-12       Impact factor: 2.574

3.  Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.

Authors:  Amy L Vincent; Wenjun Ma; Kelly M Lager; Bruce H Janke; Richard J Webby; Adolfo García-Sastre; Jürgen A Richt
Journal:  Vaccine       Date:  2007-09-29       Impact factor: 3.641

4.  Experimental H1N1pdm09 infection in pigs mimics human seasonal influenza infections.

Authors:  Theresa Schwaiger; Julia Sehl; Claudia Karte; Alexander Schäfer; Jane Hühr; Thomas C Mettenleiter; Charlotte Schröder; Bernd Köllner; Reiner Ulrich; Ulrike Blohm
Journal:  PLoS One       Date:  2019-09-20       Impact factor: 3.240

5.  Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design.

Authors:  Denise A Kaminski; F Eun-Hyung Lee
Journal:  Front Immunol       Date:  2011-12-16       Impact factor: 7.561

6.  Distinction of subtype-specific antibodies against European porcine influenza viruses by indirect ELISA based on recombinant hemagglutinin protein fragment-1.

Authors:  Na Zhao; Elke Lange; Sybille Kubald; Christian Grund; Martin Beer; Timm C Harder
Journal:  Virol J       Date:  2013-07-30       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.